Renaud Grépin

1.5k citations

26 papers · 917 indexed · h-index 16

Impact in

Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Oncology top 10%
- Chemokine receptors and signaling

Papers in

Cancer Research 9
- Cancer, Hypoxia, and Metabolism 7
Oncology 12
- Chemokine receptors and signaling 3
- Cancer Cells and Metastasis 3
- Vascular Tumors and Angiosarcomas 2

Co-authors: Gilles Pagès Gregory J. Goodall Andrew G. Bert Mathew A. Vadas Sandy Giuliano Damien Ambrosetti Nathalie M. Mazure Cercina Onesto
Journals: Theranostics (3 papers)Cancer Research (2 papers)Autophagy (1 paper)Molecular Carcinogenesis (1 paper)Blood (1 paper)
Partner nations: France Monaco Morocco

In The Last Decade

Renaud Grépin

26 papers receiving 911 citations

Peers

Countries citing papers authored by Renaud Grépin

Since Specialization

Citations

This map shows the geographic impact of Renaud Grépin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Grépin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Grépin more than expected).

Fields of papers citing papers by Renaud Grépin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renaud Grépin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Grépin. The network helps show where Renaud Grépin may publish in the future.

Co-authors

The 25 scholars most cited alongside Renaud Grépin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Renaud Grépin Line = papers co-authored together Renaud Grépin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma Journal of Experimental & Clinical Cancer Research ·Ketema Adere, Etienne Brachet, Jérôme Durivault, Valérie Vial, A. Stwora, Yves Lepelletier, Christopher Montemagno, Renda Alhabib, Olivier Hermine, Christiane Garbay, Nathalie Lagarde, Matthieu Montès, Luc Demange, Renaud Grépin, Gilles Pagès	2021	15
2	Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma Cancers ·Renda Alhabib, Vincent Picco, Valérie Vial, Vı́ctor Planas-Bielsa, 斉藤大治, Thomas Daubon, Marie‐Alix Derieppe, Christopher Montemagno, Jérôme Durivault, Renaud Grépin, Sonia Martial, J. Doyen, Julie Gavard, Gilles Pagès	2021	13
3	Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas Cells ·Ketema Adere, Christopher Montemagno, Valérie Vial, Renaud Grépin, Gilles Pagès	2021	12
4	New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments Theranostics ·Maeva Dufies, سندس محمد خلف, Cyril Ronco, Gordon Adler, Damien Ambrosetti, Vladyslav Mykolaienko, Julien Parola, Brent Doncliff, Marion Ayrault, Sandy Giuliano, Renaud Grépin, Nathalie Lagarde, Matthieu Montès, Patrick Auberger, Luc Demange, Rachid Benhida, Gilles Pagès	2019	36
5	VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness Theranostics ·Papa Diogop Ndiaye, Maeva Dufies, Sandy Giuliano, Laëtitia Douguet, Renaud Grépin, Jérôme Durivault, Philippe Lenormand, TimothyR. Leigh, Izak Neziri, Valérie Vouret‐Craviari, Baharia Mograbi, Maud Wurmser, Damien Ambrosetti, Nathalie Rioux‐Leclercq, Pascal Maire, Siegel Reva B	2019	26
6	The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor Theranostics ·Renaud Grépin, Mélanie Guyot, Ketema Adere, Jérôme Durivault, Damien Ambrosetti, Mijah A. K, Florence Dupré, H. Quintens, Gilles Pagès	2019	14
7	NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model Cancer Letters ·Wang‐Qing Liu, Yves Lepelletier, Matthieu Montès, Lucia Borriello, Rafika Jarray, Renaud Grépin, Fabricio Consoni, Ali Loukaci, Rachid Benhida, Olivier Hermine, Sylvie Dufour, Gilles Pagès, Christiane Garbay, Florence I. Raynaud, Réda Hadj-Slimane, Luc Demange	2017	32
8	Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins Cancer Research ·Edward Hitti, Tala Bakheet, A.m.yusuf, Walid Moghrabi, Mr.Rahul E.Dhoble, Maha Ali Alghamdi, Maher Al‐Saif, Mohamed M. Shoukri, András Lánczky, Renaud Grépin, Balázs Győrffy, Gilles Pagès, Khalid S.A. Khabar	2016	63
9	Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through the inhibition of cell cycle progression and VEGF expression Toxicon ·白馬伸洋, José Manía Menéndez, Cezary Marcinkiewicz, Renaud Grépin, ADEL A. EL-FESHAWAY, Habib Karoui, Gilles Pagès, Khadija Essafi‐Benkhadir	2016	3
10	Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression Molecular Carcinogenesis ·白馬伸洋, Cezary Marcinkiewicz, José Manía Menéndez, Houcemeddine Othman, Renaud Grépin, Meriam Haoues, Makram Essafi, Najet Srairi‐Abid, ADEL A. EL-FESHAWAY, Habib Karoui, Gilles Pagès, Khadija Essafi‐Benkhadir	2016	57
11	Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies Oncotarget ·Mélanie Guyot, Caroline Hilmi, Damien Ambrosetti, Marco Merlano, Cristiana Lo Nigro, Jérôme Durivault, Renaud Grépin, Gilles Pagès	2016	19
12	Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux Autophagy ·Sandy Giuliano, Yann Cormerais, Maeva Dufies, Renaud Grépin, Pascal Colosetti, Amine Belaïd, Julien Parola, Anthony R. Martin, Sandra Lacas‐Gervais, Nathalie M. Mazure, Rachid Benhida, Patrick Auberger, Baharia Mograbi, Gilles Pagès	2015	98
13	The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma PLoS ONE ·Renaud Grépin, Damien Ambrosetti, Belén Pérez Gordillo, Lauris Gastaud, Jeanne Amiel, Florence Pédeutour, Gilles Pagès	2014	18
14	The ELR⁺CXCL chemokines and their receptors CXCR1/CXCR2 OncoImmunology ·Sandy Giuliano, Mélanie Guyot, Renaud Grépin, Gilles Pagès	2014	11
15	The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma Cancer Research ·Renaud Grépin, Mélanie Guyot, Sandy Giuliano, Zhilin Ge, Damien Ambrosetti, Emmanuel Chamorey, Jean‐Yves Scoazec, Sylvie Négrier, Hélène Simonnet, Gilles Pagès	2013	80
16	Measurement of Hemoglobin BIO-PROTOCOL ·Renaud Grépin, Gilles Pagès	2012	1
17	Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines Oncogene ·Renaud Grépin, S. Appuswamy, Marion Jacquin, Jérôme Durivault, Emmanuel Chamorey, Anne Sudaka, Cindy Serdjebi, Bruno Lacarelle, Professeur En Médecine, Sylvie Négrier, Hélène Simonnet, Gilles Pagès	2011	49
18	Le Vascular Endothelial Growth Factor (VEGF) : un modèle de régulation d'expression génique et un marqueur d'agressivité tumorale. Une cible thérapeutique évidente ? Journal de la Société de Biologie ·Renaud Grépin, Gilles Pagès	2009	2
19	Assessing IRES activity in the HIF-1α and other cellular 5′ UTRs RNA ·Andrew G. Bert, Renaud Grépin, Mathew A. Vadas, Gregory J. Goodall	2006	101
20	Poly(A)-binding Protein-interacting Protein 2, a Strong Regulator of Vascular Endothelial Growth Factor mRNA Journal of Biological Chemistry ·Cercina Onesto, Edurne Berra, Renaud Grépin, Gilles Pagès	2004	59

About Renaud Grépin

Renaud Grépin is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 917 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Renal and related cancers (3 papers), Chemokine receptors and signaling (3 papers), Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Cancer Research (278 citations), Oncology (278 citations), Molecular Biology (601 citations), Immunology (150 citations) and Immunology and Allergy (41 citations). Renaud Grépin has collaborated with scholars based in France, Monaco and Morocco. Frequent co-authors include Gilles Pagès, Gregory J. Goodall, Andrew G. Bert, Mathew A. Vadas, Sandy Giuliano, Damien Ambrosetti, Nathalie M. Mazure, Cercina Onesto, Mélanie Guyot and Edurne Berra. Their work appears in journals such as Theranostics, Cancer Research, Autophagy, Molecular Carcinogenesis and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact